Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06092827

Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration

Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Universite du Quebec à Trois-Rivieres

Trois-Rivières, Quebec, G8Z 4M3, Canada

About this study

Objectives:

  • Evaluate the acceptability of a non-weight bearing physical activity (PA) program;
  • Assess the feasibility of the PA program and the data collection procedure;
  • Evaluate the feasibility of a submaximal exercise test for cardiorespiratory capacity; and
  • Verify the sensitivity of dependent variables to respond to a physical activity program (e.g., cardiorespiratory capacity, cardiovascular and metabolic risk factors, quality of life, PA level).

Type of study:

Feasibility and acceptability study with a pre-post evaluative design.

Intervention:

Intervention in the form of a PA (physical activity) program combining aerobic, resistance, and flexibility exercises adapted for wearing a lower limb offloading device and limiting weight-bearing on the feet, with a duration of twelve (12) weeks, consisting of two supervised sessions and one unsupervised home session per week.

Subjects:

  • 10-12 persons with an active diabetic foot ulcer
  • 2-3 kinesiologists

Data collection:

  • Sociodemographic and health questionnaire (age, sex, gender, marital status, education level, employment status, average annual family income, medical and health history, pharmacological and non-pharmacological treatments);
  • Feasibility assessment: PA (physical activity) logbook including 1) the number of supervised and unsupervised sessions completed, 2) the duration of each session, 3) participation rate (number of patients recruited/number of eligible patients), 4) attrition rate (number of participants who completed the follow-ups/number of participants recruited), and 5) perceived facilitators and barriers;
  • Acceptability assessment: 1) Treatment Acceptability and Preference (TAP) Questionnaire, seven to nine additional questions to assess the use of provided material resources and required safety checks (capillary blood glucose and wound inspection) and collection of participants' feedback, and 2) Client Satisfaction Questionnaire (CSQ-8);
  • Assessment of the sensitivity of dependent variables to respond to the PA program*: 1) estimation of VO2max by a submaximal exercise test on a stationary bike (Aerobic Power Index submaximal exercise test), 2) average daily step count over seven days at the waist and in the offloading boot at times 0, 4, 8, and 12 weeks, 3) Global Physical Activity Questionnaire (GPAQ), 3) clinical examination (height, weight, body mass index, waist circumference, body fat percentage, blood pressure, resting heart rate, characteristics of the DFU and classification (SINBAD), 4) paraclinical examinations (venous blood glucose, glycated hemoglobin, lipid profile), 5) neuropathic pain questionnaire (DN4), 6) Epworth sleepiness scale, quality of life questionnaire (EQ-5D-5L), 7) questionnaire on motivation to practice PA.
  • Health and safety parameter measurements: electrocardiogram, oxygen saturation, estimated glomerular filtration rate, urine albumin/creatinine ratio, complete blood count.
  • Data collection at 24 and 36 weeks is also planned for participants who agree to be contacted after completing the 12-week PA program.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

For individuals with a diabetic foot ulcer:

Inclusion:

  • Male or female
  • Aged over 18 up to 75 years
  • Willing to engage in PA (physical activity)
  • Committed to following wound care recommendations to the best of their ability for the duration of the study
  • Understand and read French.

Exclusion:

  • Uncontrolled DFU infection
  • Use of a non-removable offloading modality (total contact cast)
  • Uncontrolled hyperglycemia (HbA1c ≥ 10.0% or fasting blood glucose ≥ 16.0 mmol/L for ≥ 2 consecutive days) confirmed by blood sample results during the initial assessment or access to recent blood test results (within the last 3 months) or the log of home capillary blood glucose readings
  • Participation in sports or regular intense physical activities (≥ 2 times per week)
  • The following pre-existing heart problems: a cardiovascular event (myocardial infarction, heart surgery, etc.) in the last 3 months, unstable cardiovascular disease (uncontrolled hypertension, i.e., ≥ 160/90 mmHg, uncompensated heart failure, etc.), chest pain and exertional dyspnea and/or uninvestigated intermittent claudication
  • Recent neurovascular problem (stroke, transient ischemic attack, etc.) in the last 3 months
  • Health problem that the research team considers a contraindication to participating in the study
  • Diabetes complication making moderate-intensity PA unsafe, such as untreated proliferative diabetic retinopathy or a sensitivity disorder to hypoglycemia, critical ischemia of one or both lower limbs.

For kinesiologists:

Inclusion:

  • Have completed a bachelor's degree in kinesiology
  • Understand, read, and speak French.

Exclusion:

None

Treatment and study plan

Non weight-bearing physical activity program

Behavioral

12-week duration, 2 supervised trainings/week, 1 unsupervised home-based training/week Aerobic, resistance and flexibility exercises

Primary outcomes

  1. Feasibility of physical activity intervention

    Time frame: At time 12 weeks

    Physical activity logbook, number of sessions completed with higher number meaning a greater feasibility

  2. Acceptability of physical activity intervention

    Time frame: At time 12 weeks

    Treatment Acceptability and Preference (TAP) Questionnaire, minimum score 0/maximum score 16 with higher score meaning a greater acceptability

  3. Satisfaction towards physical activity intervention

    Time frame: At time 12 weeks

    Client Satisfaction Questionnaire (CSQ-8), minimum score 8/maximum score 32 with higher score meaning a higher satisfaction

Secondary outcomes

  1. Estimated VO2max

    Time frame: At times 0 and 12 weeks

    submaximal exercise test on a stationary bike (Aerobic Power Index submaximal exercise test), mL/kg/min

  2. Average daily step count over seven days

    Time frame: At times 0, 4, 8, and 12 weeks

    At the waist and in the offloading boot using a FitBit Zip, number of steps

  3. Physical activity level

    Time frame: At times 0 and 12 weeks

    Global Physical Activity Questionnaire (GPAQ), no minimum/maximum, details number of minutes/number of days per week of physical activity according to type of activity (work, leisures, commute, sedentary time)

  4. Height

    Time frame: At time 0

    Standing with rigid measuring rod, cm

  5. Weight

    Time frame: At times 0 and 12 weeks

    Standing on beam balance scale, kg

  6. Waist circumference

    Time frame: At times 0 and 12 weeks

    With flexible measuring tape above ombilic, cm

  7. Body fat percentage

    Time frame: At times 0 and 12 weeks

    With bio-impedance balance, %

  8. Arterial blood pressure

    Time frame: At times 0 and 12 weeks

    With automatic blood pressure monitor, mm Hg

  9. Resting heart rate

    Time frame: At times 0 and 12 weeks

    With automatic blood pressure monitor, bpm

  10. Wound measurements (width, length, depth)

    Time frame: At times 0, 4, 8 and 12 weeks

    With flexible ruler

  11. Classification of the ulcer

    Time frame: At times 0, 4, 8 and 12 weeks

    Using SINBAD system, 6 categories graded 0 or 1 for a minimum of 0 and maximum of 6, with higher score meaning a more complicated ulcer

  12. Non fasting venous blood glucose

    Time frame: At times 0 and 12 weeks

    With venipuncture, mmol/L

  13. Glycated hemoglobin

    Time frame: At times 0 and 12 weeks

    With venipuncture, %

  14. Lipid profile (total cholesterol, low density lipoprotein, high density lipoprotein, triglycerides, non-HDL cholesterol)

    Time frame: At times 0 and 12 weeks

    Venipuncture, g/L

  15. Neuropathic pain (if present)

    Time frame: At times 0 and 12 weeks

    Neuropathic pain (DN4) Questionnaire, 10 yes/no questions, higher number of yes indicates more severe neuropathic pain

  16. Sleep apnea symptoms

    Time frame: At times 0 and 12 weeks

    Epworth sleepiness scale, minimum score of 0/maximum score of 24, higher score makes sleep apnea more likely

  17. Reported quality of life

    Time frame: At times 0 and 12 weeks

    Quality of life questionnaire (EQ-5D-5L), minimum score of 5/maximum of 25 + 10cm visual analog scale, higher score represents a lower quality of life + 10cm being the best health condition possible

  18. Questionnaire on motivation to practice physical activity

    Time frame: At times 0 and 12 weeks

    With the Behavioural Regulation in Exercise revised Questionnaire (BREQ-2), 5 motivation categories graded from 0 to 4, Intrinsic (4 questions), Identified (3 questions), Introjected (3 questions), External (4 questions) and Amotivation (4 questions), with lower scores meaning lesser motivation for each category

Other outcomes

  1. Resting electrocardiogram (safety parameter)

    Time frame: At time 0

    To detect ST-T abnormalities at rest which has been shown to be most predictive for silent ischemia

  2. Estimated glomerular filtration rate (safety parameter)

    Time frame: At times 0 and 12 weeks

    With venipuncture, mL/min. Results lower than 15 mL/min will need a specialist consultation to get medical clearance

  3. Urine albumin/creatinine ratio (safety parameter)

    Time frame: At times 0 and 12 weeks

    With urinalysis, mg/g. Results lower than 300 mg/g will need a specialist consultation to get medical clearance

  4. Hemoglobin (safety parameter)

    Time frame: At times 0 and 12 weeks

    With venipuncture, g/L. Results lower than 100 g/L will need a specialist consultation to get medical clearance

Sponsors and collaborators

Lead sponsor

Université du Québec à Trois-Rivières

Other

Collaborators

  • Centre intégré universitaire de santé et services sociaux Mauricie et Centre-du-Québec (CIUSSS MCQ)
  • Fondation Santé Trois-Rivières
  • Université de Montréal

Registry information

Official study title

Feasibility and Acceptability Study of a Non Weight-bearing Physical Activity Program for People With Diabetic Foot Ulceration (DB ACTIV)

Acronym: DB-ACTIV

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Oct 23, 2023
Registry last updated
May 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.